About us Pricing ContactSubscribe

J

Jeffrey A. Engelman

Albert Einstein College of MedicineORCID https://orcid.org/0009-0004-0775-4523

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Science Translational Medicine20113,534 citationsCorresponding

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Nature Reviews Genetics20063,288 citationsFirst authorCorresponding

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Nature reviews. Cancer20092,438 citationsFirst authorCorresponding

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Science Translational Medicine20121,320 citationsCorresponding

<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis

Clinical Cancer Research20161,214 citations

Caveolins, Liquid-Ordered Domains, and Signal Transduction

Molecular and Cellular Biology19991,005 citationsCorresponding

<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Clinical Cancer Research2008975 citations

Jeffrey A. Engelman · Scinovex